Royalty Pharma (RPRX) Stock Forecast for 2024, 2025, 2026. Sell or Buy Prediction







Advanced Charting Tools For Traders

January 1, 2025 Advanced Charting Tools For Traders

Ever tried deciphering market trends with the intensity of a detective peering over cryptic clues? Enter the realm of Advanced Charting, where complex…
Why Is Trading Important?

December 21, 2024 Why Is Trading Important?

Trade isn’t just figures on a spreadsheet; it’s the pulse of our global community. In 2018, the United States faced a staggering $621…
Best AI Trading & Performance Tools

December 21, 2024 Best AI Trading & Performance Tools

Ever find yourself overwhelmed by the rapid twists and turns of the stock market? I know the feeling—one moment you’re riding high, and…
Best Economic Calendars For Traders

December 21, 2024 Best Economic Calendars For Traders

You know that feeling when a crucial financial announcement catches you off guard, and suddenly your trading plans are turned upside down? We’ve…
When to Switch Payroll Solutions and How to Make a Smooth Transition

December 9, 2024 When to Switch Payroll Solutions and How to Make a Smooth Transition

Payroll solutions are important for every business, as without them, you cannot make the right choices and calculations in your payment system. However,…

Royalty Pharma (RPRX) Stock Forecast for 2024, 2025, 2026. Sell or Buy?

Updated: January 17, 2025 (06:26)

Sector: Healthcare

The share price of Royalty Pharma plc (RPRX) now

Latest session on the 16th of January for
Royalty Pharma plc is positive
Trading Volume: 4829577
Open: 30.64 /  High: 31.09 /  Low: 30.112
What analysts predict: $40.66
52-week High/Low: $30.92 / $24.05
50-Day Moving Average: $26.16 — support level today
200-Day Moving Average: $27.33 — support level today

Are you interested in Royalty Pharma plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Royalty Pharma stock price in 2025, 2026, 2027. How much will one Royalty Pharma share be worth in 2025 - 2027?

When should I take profit in Royalty Pharma stock? When should I record a loss on Royalty Pharma stock? What are analysts' forecasts for Royalty Pharma stock? What is the future of Royalty Pharma stock? We forecast Royalty Pharma stock performance using neural networks based on historical data on Royalty Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Royalty Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Royalty Pharma shares. This happens once a day.


Historical and forecast chart of Royalty Pharma stock

The chart below shows the historical price of Royalty Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Royalty Pharma stock price can be found in the table below.

Long-term forecasts by years.

Royalty Pharma plc is a biopharmaceutical royalty purchaser and innovation sponsor for the US biopharmaceutical industry. He is also involved in identifying, evaluating and obtaining royalties for various biopharmaceuticals. In addition, the company partners with innovators from academic institutions, research hospitals and non-profit organizations, small and medium-sized biotech companies, and pharmaceutical companies.

Trending Themes in the Healthcare Sector

Royalty Pharma daily forecast for a month

Date Target Pes. Opt. Vol., %
Jan 19 30.72 30.28 31.21 3.07
Jan 20 30.78 30.19 31.20 3.33
Jan 21 31.02 30.61 31.23 2.04
Jan 22 30.16 29.79 30.72 3.13
Jan 23 30.39 30.11 30.82 2.36
Jan 24 31.20 30.51 31.83 4.33
Jan 25 31.29 31.08 31.86 2.51
Jan 26 30.87 30.17 31.15 3.25
Jan 27 31.21 30.59 31.75 3.80
Jan 28 31.67 31.24 32.02 2.49
Jan 29 31.01 30.80 31.47 2.21
Jan 30 31.75 31.12 32.08 3.06
Jan 31 31.64 30.99 31.97 3.15
Feb 01 31.20 30.87 31.72 2.76
Feb 02 31.03 30.59 31.75 3.80
Feb 03 30.59 30.29 31.01 2.36
Feb 04 31.29 30.60 31.76 3.80
Feb 05 31.94 31.65 32.16 1.60
Feb 06 32.40 31.63 32.61 3.07
Feb 07 31.88 31.63 32.50 2.75
Feb 08 31.49 30.99 31.91 2.96
Feb 09 30.60 30.35 30.83 1.57
Feb 10 30.27 29.60 30.96 4.60
Feb 11 30.47 30.25 30.82 1.90
Feb 12 30.88 30.47 31.21 2.43
Feb 13 30.59 30.00 30.85 2.81
Feb 14 30.29 29.81 30.84 3.44
Feb 15 30.07 29.56 30.50 3.17
Feb 16 29.77 29.20 30.07 3.00
Feb 17 29.92 29.36 30.40 3.55

Royalty Pharma Daily Price Targets


Royalty Pharma Stock Forecast 01-19-2025.

Forecast target price for 01-19-2025: $30.72.
Negative dynamics for Royalty Pharma shares will prevail with possible volatility of 2.982%.
Pessimistic target level: 30.28
Optimistic target level: 31.21

Royalty Pharma Stock Forecast 01-20-2025.

Forecast target price for 01-20-2025: $30.78.
Positive dynamics for Royalty Pharma shares will prevail with possible volatility of 3.226%.
Pessimistic target level: 30.19
Optimistic target level: 31.20

Royalty Pharma Stock Forecast 01-21-2025.

Forecast target price for 01-21-2025: $31.02.
Positive dynamics for Royalty Pharma shares will prevail with possible volatility of 1.996%.
Pessimistic target level: 30.61
Optimistic target level: 31.23

Royalty Pharma Stock Forecast 01-22-2025.

Forecast target price for 01-22-2025: $30.16.
Negative dynamics for Royalty Pharma shares will prevail with possible volatility of 3.033%.
Pessimistic target level: 29.79
Optimistic target level: 30.72

Royalty Pharma Stock Forecast 01-23-2025.

Forecast target price for 01-23-2025: $30.39.
Positive dynamics for Royalty Pharma shares will prevail with possible volatility of 2.307%.
Pessimistic target level: 30.11
Optimistic target level: 30.82

Royalty Pharma Stock Forecast 01-24-2025.

Forecast target price for 01-24-2025: $31.20.
Positive dynamics for Royalty Pharma shares will prevail with possible volatility of 4.147%.
Pessimistic target level: 30.51
Optimistic target level: 31.83

RPRX (RPRX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Feb. 32.81 32.35 33.66 3.89
Mar. 31.86 30.26 33.60 9.96
Apr. 31.84 30.66 33.36 8.09
May. 32.31 31.61 33.85 6.62
Jun. 30.46 29.05 31.09 6.58
Jul. 31.29 30.48 32.56 6.39
Aug. 31.75 30.88 33.28 7.21
Sep. 32.68 31.24 33.73 7.39
Oct. 31.83 30.72 32.28 4.83
Nov. 33.06 31.72 33.61 5.65
Dec. 33.22 31.36 34.92 10.19

Royalty Pharma forecast for this year


Royalty Pharma Stock Prediction for Feb 2025

An uptrend is forecast for this month with an optimal target price of $32.8057. Pessimistic: $32.35. Optimistic: $33.66


Royalty Pharma Stock Prediction for Mar 2025

An downtrend is forecast for this month with an optimal target price of $31.8642. Pessimistic: $30.26. Optimistic: $33.60


Royalty Pharma Stock Prediction for Apr 2025

An downtrend is forecast for this month with an optimal target price of $31.8419. Pessimistic: $30.66. Optimistic: $33.36


Royalty Pharma Stock Prediction for May 2025

An uptrend is forecast for this month with an optimal target price of $32.31. Pessimistic: $31.61. Optimistic: $33.85


Royalty Pharma Stock Prediction for Jun 2025

An downtrend is forecast for this month with an optimal target price of $30.4554. Pessimistic: $29.05. Optimistic: $31.09


Royalty Pharma Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $31.2868. Pessimistic: $30.48. Optimistic: $32.56


Royalty Pharma Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $31.7467. Pessimistic: $30.88. Optimistic: $33.28


Royalty Pharma Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $32.6801. Pessimistic: $31.24. Optimistic: $33.73


Royalty Pharma Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $31.8337. Pessimistic: $30.72. Optimistic: $32.28


Royalty Pharma Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $33.0593. Pessimistic: $31.72. Optimistic: $33.61


Royalty Pharma Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $33.2213. Pessimistic: $31.36. Optimistic: $34.92



Royalty Pharma (RPRX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 33.36 32.05 34.44 6.92
Feb 35.14 33.36 36.14 7.69
Mar 36.91 35.20 38.30 8.09
Apr 39.18 38.17 40.63 6.07
May 40.11 37.89 41.18 7.98
Jun 42.36 41.53 43.34 4.17
Jul 41.20 39.90 42.85 6.87
Aug 39.88 38.84 41.91 7.33
Sep 39.48 38.66 40.48 4.51
Oct 37.22 36.28 38.76 6.39
Nov 36.96 35.53 37.99 6.47
Dec 37.94 36.77 39.99 8.04

Royalty Pharma (RPRX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 37.33 36.39 38.72 6.01
Feb 38.48 37.11 40.31 7.95
Mar 38.13 37.25 38.90 4.25
Apr 39.25 38.10 40.68 6.35
May 37.27 35.65 38.97 8.50
Jun 38.55 37.15 39.23 5.30
Jul 38.52 37.36 39.60 5.65
Aug 37.88 36.23 39.81 8.99
Sep 39.20 37.28 39.89 6.54
Oct 37.97 37.17 39.99 7.05
Nov 39.64 37.98 41.45 8.37
Dec 41.81 41.02 43.27 5.21

Royalty Pharma information and performance

Royalty Pharma Address

110 EAST 59TH STREET, NEW YORK, NY, US

Market Capitalization: 18 111 484 000 $

Market capitalization of the Royalty Pharma plc is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of RPRX shares in the company outstanding by the market price of one share.

EBITDA: 1 497 820 000 $

EBITDA of Royalty Pharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: 12.1

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 6.67

Price/earnings to growth

DPS: 0.83

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0286

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 2.54

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 6.59
Quarterly Revenue Growth YOY: 0.053
Trailing PE: 12.1

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 10.34

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 8.61

Enterprise Value (EV) /Revenue

EV To EBITDA: 10.15

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 444302000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Royalty Pharma (RPRX) stock dividend

Royalty Pharma last paid dividends on 02/21/2025. The next scheduled payment will be on 12/10/2024. The amount of dividends is $0.83 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.